-
Analyst Opinions
NewUnited Kingdom (UK) Commercial Insurance Distribution Dynamics by Channels and Future Market, 2024 Update
This report discusses the distribution landscape of UK commercial insurance. Each channel is discussed in turn, with a particular focus on the broker channel, which dominates the space. Analysis of responses to GlobalData’s 2024 UK Commercial Insurance Broker Survey offers insight into brokers’ growth and digital transformation strategies going forward. The SME market is also discussed, with due consideration given to smaller businesses and their comparatively simple insurance needs. The report finishes by providing an outlook on the future of...
-
Thematic Analysis
Ukraine Conflict Impact – Thematic Intelligence
Reasons to buy the ‘Ukraine Conflict Impact’ thematic intelligence report: Find out who are the leading players in the Ukraine war impact theme, and where they sit in the value chain. Gain in-depth insight into the main trends shaping the Ukraine War Impact theme over the next 12 to 24 months; classified into three categories: technology trends, macroeconomic trends, and regulatory trends. Identify the leading companies and the key disruptor companies making their mark within the Ukraine War Impact theme....
-
Sector Analysis
Automated Homes Market Size, Share, Trends, and Analysis by Device Type, Region and Segment Forecast to 2030
Accessing the in-depth insights from the ‘Automated Homes’ report can help you: Make informed decisions about market entry, technology adoption, and project planning. Identify competitors' capabilities to stay ahead in the market. Identify promising device segments, growth trends, regional trends, and markets to expand your regional presence, product portfolio, and discover successful investment opportunities. Anticipate changes in demand and adjust business development strategies. Identify ongoing potential projects across regions. How is our ‘Automated Homes’ report different from other reports in the market? The report presents in-depth market sizing information...
-
Product Insights
Hemorrhagic Fever – Drugs In Development, 2023
Global Markets Direct’s, ‘Hemorrhagic Fever - Drugs In Development, 2023’, provides an overview of the Hemorrhagic Fever pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hemorrhagic Fever, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Infectious Diarrhea – Drugs In Development, 2023
Global Markets Direct’s, ‘Infectious Diarrhea - Drugs In Development, 2023’, provides an overview of the Infectious Diarrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Infectious Diarrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Septic Shock – Drugs In Development, 2023
Global Markets Direct’s, ‘Septic Shock - Drugs In Development, 2023’, provides an overview of the Septic Shock pipeline landscape. The report provides comprehensive information on the therapeutics under development for Septic Shock, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Equine Encephalitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Equine Encephalitis - Drugs In Development, 2023’, provides an overview of the Equine Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Equine Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Eastern Equine Encephalitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Eastern Equine Encephalitis - Drugs In Development, 2023’, provides an overview of the Eastern Equine Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Eastern Equine Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Western Equine Encephalitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Western Equine Encephalitis - Drugs In Development, 2023’, provides an overview of the Western Equine Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Western Equine Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Venezuelan Equine Encephalitis – Drugs In Development, 2023
Global Markets Direct’s, ‘Venezuelan Equine Encephalitis - Drugs In Development, 2023’, provides an overview of the Venezuelan Equine Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Venezuelan Equine Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...